Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

Ithai Waldhorn; Roy Holland; Tal Goshen-Lago; Madeleine Benguigui; Michael Halberthal; Yuval Shaked; Irit Ben-Aharon

doi:10.1001/jamaoncol.2022.1467

Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

Ithai Waldhorn, Roy Holland, Tal Goshen-Lago, Madeleine Benguigui, Michael Halberthal, Yuval Shaked, Irit Ben-Aharon

Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	JAMA Oncology
Volume	8
Issue number	6
DOIs	https://doi.org/10.1001/jamaoncol.2022.1467
State	Published - 22 Apr 2022

Keywords

BNT162 Vaccine
Humans
Neoplasms
Vaccines

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2022.1467

Cite this

@article{2f383b1ea4ab415d845546ef95c29dab,

title = "Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors",

keywords = "BNT162 Vaccine, Humans, Neoplasms, Vaccines",

author = "Ithai Waldhorn and Roy Holland and Tal Goshen-Lago and Madeleine Benguigui and Michael Halberthal and Yuval Shaked and Irit Ben-Aharon",

year = "2022",

month = apr,

day = "22",

doi = "10.1001/jamaoncol.2022.1467",

language = "אנגלית",

volume = "8",

pages = "1--2",

number = "6",

}

TY - JOUR

T1 - Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

AU - Waldhorn, Ithai

AU - Holland, Roy

AU - Goshen-Lago, Tal

AU - Benguigui, Madeleine

AU - Halberthal, Michael

AU - Shaked, Yuval

AU - Ben-Aharon, Irit

PY - 2022/4/22

Y1 - 2022/4/22

KW - BNT162 Vaccine

KW - Humans

KW - Neoplasms

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=85129405431&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2022.1467

DO - 10.1001/jamaoncol.2022.1467

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 35452089

AN - SCOPUS:85129405431

SN - 2374-2437

VL - 8

SP - 1

EP - 2

JO - JAMA Oncology

JF - JAMA Oncology

IS - 6

ER -

Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this